- Long-term follow-up of patients developing gastric mucosal lesions after initiating the potassium-competitive acid blocker vonoprazan
-
Kubo K, Kimura N
- KMID: 2558114
- Clin Endosc.
- 2024 Jul;57(4):549-551.
- doi: 10.5946/ce.2023.186
-
- CITED
-
- Close
- SHARE
-
- Close
- Potassium-competitive acid blocker-associated gastric mucosal lesions
-
Kubo K, Kimura N, Kato M
- KMID: 2558095
- Clin Endosc.
- 2024 Jul;57(4):417-423.
- doi: 10.5946/ce.2023.279
Since the introduction of vonoprazan, a potassium-competitive acid blocker (P-CAB), it has been demonstrated to reversibly inhibit gastric acid secretion by engaging in potassium-competitive ionic binding to H+/K+-ATPase. In contrast,... -
- CITED
-
- Close
- SHARE
-
- Close
